Advertisement
The Body: The Complete HIV/AIDS Resource Follow Us Follow Us on Facebook Follow Us on Twitter
Professionals >> Visit The Body PROThe Body en Espanol
  
  • Email Email
  • Printable Single-Page Print-Friendly
  • Glossary Glossary

Index to Volume 3 of HIV Newsline

An Alphabetical Listing of Article Titles and Subjects Covered in the Third Year of Publication

Decmber 1997

In the past year HIV Newsline has provided its readers -- 27,566 office-based clinicians and other healthcare providers -- with 174 pages of timely information on the latest advances in the treatment of patients with HIV infection, 14 pages more than the previous year. The dissemination of this information -- at no charge to recipients -- has been made possible by unrestricted educational grants from the sponsors listed below. Their continuing support in 1998 will enable us to continue to fulfill the editorial mission that Dr. Paul A. Volberding, Editor-in-Chief of HIV Newsline, set forth in our first issue: "To provide clinicians with pertinent, practical, up-to-the-minute information on the diagnosis and long-term management of one of the most complex disease entities ever confronted by healthcare providers."

Over the past year HIV Newsline has published articles, editorials, late-breaking news items, and brief commentaries on a wide range of subjects, from the management of pain in end-stage HIV disease to the diagnosis and treatment of multidrug-resistant TB. We devoted one entire issue to HIV disease in women and children, and another to the immediate future of antiretroviral therapy.

In response to overwhelming demand from our readers, their patients, and AIDS service organizations, we reprinted and distributed 7,500 copies of "Mastering Combination Therapy," a Pull Out and Save feature that appeared in the April issue of our sister publication, AIDS Care. At her specific request, we added President Clinton's new AIDS czar -- and all the members of the President's AIDS Advisory Council -- to our mailing list.

Advertisement
We will continue to provide readable, relevant, reliable information to our readers in the coming year -- to assist them in providing their patients with continuing care that is clinically sound, cost-effective, and compassionate.


The publication of HIV Newsline is supported by unrestricted educational grants from:

Glaxo Wellcome

Bristol-Myers Squibb

Roche Laboratories

Amgen

Pfizer


The following index is arranged alphabetically by article title and by subject matter. Page numbers are provided for all entries except those that come from the unpaginated Pull Out and Save inserts that appear in every issue of HIV Newsline. The titles and subject matter of those inserts are listed by issue number.


Index: HIV Newsline, Volume 3

ALPHABETICAL LISTING | PULL-OUT INSERTS

SUBJECT LISTING:

Antiretrovirals

Opportunistic Infections and Other Conditions

Prevention / Transmission | Pediatrics

Case Studies | General


Alphabetical Listing Page

ACTG 268: gradual vs. routine initiation of PCP prophylaxis

27
A good year, and the promise of a better one 131
A kiss is just a kiss 107
Antiretroviral therapy in children 96
Antiretroviral therapy in pregnant women 86
Approval sought for new formulation of saquinavir 64
At last, a protease inhibitor for children 18
Broad-based prevention programs have little impact on high-risk behavior 119
CDC reports substantial drop in AIDS deaths 36
Challenge of multidrug-resistant TB 108
Cidofovir for CMV retinitis 38
Cidofovir gel heals herpes lesions 137
Clinical significance of surrogate markers 57
Clinton administration proposes extending Medicaid to people with HIV 62
Combinations of reverse transcriptase inhibitors in children 92
Compliance: How you can help 67
Drug-drug interactions -- an update 140
Drug-resistant TB: Who is at risk? 115
Enthusiasm tempered by caution 51
Enhancing saquinavir levels with ritonavir 60
First genotypic test for HIV resistance 139
Gammaglobulin prevents infections 141
Guidelines for administration of protease inhibitors and rifampin in HIV-positive patients with TB 116
Highlights of the 4th Conference 19
HIV/AIDS debate is over 3
HIV found in patients with "undetectable" viral levels 141
In treating MAC, less may be more 58
Isoniazid in HIV-positive patients at high risk for TB 113
Is resistance always a bad thing? 59
Joan J: A treatment-naïve patient who isn't naïve about treatment options 121
John L: A previously untreated patient with a CD4 count above 500 10
Low-dose AZT is effective in children 92
More on how HIV enters cells 137
Nevirapine in combination with protease inhibitors 16
New formulation of saquinavir 138
New macrolide inhibits late-stage HIV replication 63
Next generation of antiretroviral agents 73
Next generation of antiretroviral agents -- an update 143
Oral AZT may be equal to IV during delivery 95
Oral suspension of itraconazole effective against refractory candidiasis 14
Oxandralone for wasting syndrome 33
Paramomycin ineffective against cryptosporidiosis 34
Peter S: An extensively treated patient with rising viral load 29
Predictors of TB infection 113
Preventing vertical transmission: A wise investment 83
Problem of azole-resistant candidiasis 24
Problem of protease resistance 52
Protease inhibitor resistance and salvage therapy 132
Regression of PML in an aggressively treated patient 34
Risk factors and perinatal transmission 94
Skills-building prevention programs 118
Smoking increases risk of cryptococcosis 37
Study finds treatment of pain inadequate in AIDS patients 37
Transmission can be reduced among IVDUs 120
   
Pull-Out Inserts Issue
Starting your patient on an antiretroviral regimen I
Guide to management of severe pain in HIV-infected patients II
Strategies to establish and maintain optimal adherence III
U.S. Public Health Service recommendationsfor use of antiretroviral drugs during pregnancy IV
Foods that can be eaten in conjunction with Crixivan V
Optimal antiretroviral therapy for HIV infection VI
   
Subject Listing Page
(Listed in temporal order of publication)
Antiretrovirals

Nevirapine in combination with protease inhibitors

16
At last, a protease inhibitor for children 18
Highlights of the 4th Conference on Retroviruses 19
Management of pain in end-stage HIV disease 39
Enthusiasm tempered by caution 51
Problem of protease resistance 52
Is resistance always a bad thing? 59
Enhancing saquinavir levels with ritonavir 60
New macrolide inhibits late-stage HIV replication 63
Approval sought for new formulation of saquinavir 64
Compliance: How you can help 67
Next generation of antiretroviral agents 73
Antiretroviral therapy in pregnant women 86
Low-dose AZT is effective in children 92
Triple-drug therapy in infants 93
Oral AZT may be equal to IV during delivery 95
Antiretroviral therapy in children 96
Guidelines for administration of protease inhibitors and rifampin in HIV-positive patients with TB 116
Protease inhibitor resistance and salvage therapy 132
New formulation of saquinavir 138
Next generation of antiretroviral agents -- an update 143
   
Opportunistic Infections and Other Conditions

Oral suspension of itraconazole effective against refractory candidiasis

14
Problem of azole-resistant candidiasis 24
ACTG 268: gradual vs. routine initiation of PCP prophylaxis 27
Oxandralone for wasting syndrome 33
Paramomycin ineffective against cryptosporidiosis 34
Regression of PML in an aggressively treated patient 34
Smoking increases risk of cryptococcosis 37
Cidofovir for CMV retinitis 38
In treating MAC, less may be more 58
Triple-drug therapy in infants 93
Challenge of multidrug-drug resistant TB 108
Isoniazid in HIV-positive patients at high risk for TB 113
Predictors of TB infection 113
Drug-resistant TB: Who is at risk? 115
Guidelines for administration of protease inhibitors and rifampin in HIV-positive patients with TB 116
Cidofovir gel heals herpes lesions 137
Gammaglobulin prevents infections 141
   
Prevention / Transmission

Preventing vertical transmission: A wise investment

83
Risk factors and perinatal transmission 94
A kiss is just a kiss 107
Skills-building prevention programs 118
Broad-based prevention programs have little impact on high-risk behavior 119
Transmission can be reduced among IVDUs 120
   
Pediatrics

At last, a protease inhibitor for children

18
Combinations of reverse transcriptase inhibitors in children 92
Low-dose AZT is effective in children 92
Triple-drug therapy in infants 93
Oral AZT may be equal to IV during delivery 95
Antiretroviral therapy in children 96
   
Case Studies

John L: A previously untreated patient with a CD4 count above 500

10
Peter S: An extensively treated patient with rising viral load 29
Joan J: A treatment-naïve patient who isn't naïve about treatment options 121
   
General
HIV/AIDS debate is over 3
CDC reports substantial drop in AIDS deaths 36
Study finds treatment of pain inadequate in AIDS patients 37
Management of pain in end-stage HIV disease 39
Clinical significance of surrogate markers 57
Clinton administration proposes extending Medicaid to people with HIV 62
First genotypic test for HIV resistance 139
HIV found in patients with "undetectable" viral levels 141
More on how HIV enters cells 137
Drug-drug interactions -- an update 140



  
  • Email Email
  • Printable Single-Page Print-Friendly
  • Glossary Glossary

This article was provided by San Francisco General Hospital. It is a part of the publication HIV Newsline.
 

 

Advertisement